BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35679757)

  • 21. Generation of a control induced pluripotent stem cell line (SDUCHi001-A) from a healthy male donor.
    Li C; Zhang F; Wang X; Chen M
    Stem Cell Res; 2024 Jun; 77():103433. PubMed ID: 38718593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.
    Tsukamoto M; Kimura K; Yoshida T; Tanaka M; Kuwamura M; Ayabe T; Ishihara G; Watanabe K; Okada M; Iijima M; Nakanishi M; Akutsu H; Sugiura K; Hatoya S
    Stem Cell Reports; 2024 Jan; 19(1):141-157. PubMed ID: 38134923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
    Wang YB; Lv YF; Zhang Y; Wang W
    Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
    Li YP; Liu H; Jin ZB
    Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a human induced pluripotent stem cell line (OGIi001) from peripheral blood mononuclear cells of a healthy male donor.
    Zhang H; Daheron L; Cerna-Chavez R; Place EM; Huckfeldt RM; Pierce EA; Garita-Hernandez M
    Stem Cell Res; 2024 Feb; 74():103280. PubMed ID: 38134577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.
    Fieldes M; Ahmed E; Bourguignon C; Mianné J; Martin M; Arnould C; Vachier I; Assou S; De Vos J; Bourdin A
    Stem Cell Res; 2020 Dec; 49():102037. PubMed ID: 33099111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells of different genders.
    Gao Y; Cheng Y; Lin B; Xiao D; Wen J; Xu J; Zheng R; Zhang M; Cai C; Hu J
    Stem Cell Res; 2024 Jun; 77():103421. PubMed ID: 38636268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma.
    Chen K; Zhuang Z; Wang Q; Li K; Xu S; Liu M; Zhang K; Wei L; Zhang Y; Lian H; Zhang B; Zhong C
    Stem Cell Res; 2021 Oct; 56():102546. PubMed ID: 34587579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation and characterization of IMAGINi013-A, an induced pluripotent stem cell line generated from a healthy donor.
    Banal C; Lefort N
    Stem Cell Res; 2022 May; 61():102755. PubMed ID: 35334405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML).
    Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X
    Stem Cell Res; 2024 Jun; 77():103360. PubMed ID: 38608356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor.
    Xi Y; Zhang H; Yang X; Ai D; Liu Y; Song W
    Stem Cell Res; 2023 Sep; 71():103160. PubMed ID: 37429069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions.
    Hansel MC; Gramignoli R; Blake W; Davila J; Skvorak K; Dorko K; Tahan V; Lee BR; Tafaleng E; Guzman-Lepe J; Soto-Gutierrez A; Fox IJ; Strom SC
    Cell Transplant; 2014 Jan; 23(1):27-38. PubMed ID: 23394081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derivation of a human induced pluripotent stem cell (hiPSC) line (PUMCSMi001-A) from peripheral blood mononuclear cells of one healthy female donor.
    Du M; Li L; Hu Y; Mi H; Wang T
    Stem Cell Res; 2021 May; 53():102312. PubMed ID: 33812336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual.
    Shang S; Chen K; Cai G; Bai X; Chen X; Li Q
    Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
    Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of SIAISi021-A, an induced pluripotent stem cell (iPSC) line from a 71-year-old Chinese Han male with Alzheimer's Disease (AD) having two copies of APOE4/4 allele.
    Ding Y; Chen H; Zhao J; Wang Y; Deng Y
    Stem Cell Res; 2022 Aug; 63():102866. PubMed ID: 35843023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male.
    Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S
    Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.